Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection
Abstract The novel coronavirus SARS-CoV-2 continues to cause death and disease throughout the world, underscoring the necessity of understanding the virus and host immune response. From the start of the pandemic, a prominent pattern of central nervous system (CNS) pathologies, including demyelinatio...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-27348-8 |
_version_ | 1828069698789441536 |
---|---|
author | Camille M. Lake Joseph J. Breen |
author_facet | Camille M. Lake Joseph J. Breen |
author_sort | Camille M. Lake |
collection | DOAJ |
description | Abstract The novel coronavirus SARS-CoV-2 continues to cause death and disease throughout the world, underscoring the necessity of understanding the virus and host immune response. From the start of the pandemic, a prominent pattern of central nervous system (CNS) pathologies, including demyelination, has emerged, suggesting an underlying mechanism of viral mimicry to CNS proteins. We hypothesized that immunodominant epitopes of SARS-CoV-2 share homology with proteins associated with multiple sclerosis (MS). Using PEPMatch, a newly developed bioinformatics package which predicts peptide similarity within specific amino acid mismatching parameters consistent with published MHC binding capacity, we discovered that nucleocapsid protein shares significant overlap with 22 MS-associated proteins, including myelin proteolipid protein (PLP). Further computational evaluation demonstrated that this overlap may have critical implications for T cell responses in MS patients and is likely unique to SARS-CoV-2 among the major human coronaviruses. Our findings substantiate the hypothesis of viral molecular mimicry in the pathogenesis of MS and warrant further experimental exploration. |
first_indexed | 2024-04-11T00:23:15Z |
format | Article |
id | doaj.art-b515534ece07403cae84ad49a47908bf |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-04-11T00:23:15Z |
publishDate | 2023-01-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-b515534ece07403cae84ad49a47908bf2023-01-08T12:09:31ZengNature PortfolioScientific Reports2045-23222023-01-0113111510.1038/s41598-022-27348-8Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infectionCamille M. Lake0Joseph J. Breen1Office of Data Science and Emerging Technologies, National Institute of Allergy and Infectious DiseasesDivision of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious DiseasesAbstract The novel coronavirus SARS-CoV-2 continues to cause death and disease throughout the world, underscoring the necessity of understanding the virus and host immune response. From the start of the pandemic, a prominent pattern of central nervous system (CNS) pathologies, including demyelination, has emerged, suggesting an underlying mechanism of viral mimicry to CNS proteins. We hypothesized that immunodominant epitopes of SARS-CoV-2 share homology with proteins associated with multiple sclerosis (MS). Using PEPMatch, a newly developed bioinformatics package which predicts peptide similarity within specific amino acid mismatching parameters consistent with published MHC binding capacity, we discovered that nucleocapsid protein shares significant overlap with 22 MS-associated proteins, including myelin proteolipid protein (PLP). Further computational evaluation demonstrated that this overlap may have critical implications for T cell responses in MS patients and is likely unique to SARS-CoV-2 among the major human coronaviruses. Our findings substantiate the hypothesis of viral molecular mimicry in the pathogenesis of MS and warrant further experimental exploration.https://doi.org/10.1038/s41598-022-27348-8 |
spellingShingle | Camille M. Lake Joseph J. Breen Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection Scientific Reports |
title | Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection |
title_full | Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection |
title_fullStr | Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection |
title_full_unstemmed | Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection |
title_short | Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection |
title_sort | sequence similarity between sars cov 2 nucleocapsid and multiple sclerosis associated proteins provides insight into viral neuropathogenesis following infection |
url | https://doi.org/10.1038/s41598-022-27348-8 |
work_keys_str_mv | AT camillemlake sequencesimilaritybetweensarscov2nucleocapsidandmultiplesclerosisassociatedproteinsprovidesinsightintoviralneuropathogenesisfollowinginfection AT josephjbreen sequencesimilaritybetweensarscov2nucleocapsidandmultiplesclerosisassociatedproteinsprovidesinsightintoviralneuropathogenesisfollowinginfection |